GoodRx Holdings (GDRX) Shares Outstanding (2019 - 2026)

GoodRx Holdings' Shares Outstanding history runs 8 years deep, the most recent figure standing at $337.6 million for Q1 2026.

• In Q1 2026, Shares Outstanding fell 6.44% year-over-year to $337.6 million; the TTM figure through Mar 2026 stood at $337.6 million (down 6.44% YoY), while the FY2025 annual figure was $341.1 million, down 10.91% from the prior year.
• Shares Outstanding came in at $337.6 million for Q1 2026 at GoodRx Holdings, down from $341.1 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $398.4 million in Q3 2023 to a low of $337.6 million in Q1 2026.
• A 5-year average of $377.8 million and a median of $382.8 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding increased 0.94% in 2022 and dropped 10.91% in 2025, its largest moves.
• GoodRx Holdings' Shares Outstanding stood at $397.0 million in 2022, then declined by 0.74% to $394.1 million in 2023, then slipped by 2.86% to $382.8 million in 2024, then retreated by 10.91% to $341.1 million in 2025, then fell by 1.02% to $337.6 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $337.6 million, $341.1 million, and $341.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison